Astrana Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . Astrana Health
ASTH Stock   19.03  0.24  1.25%   
Astrana Health's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Astrana Health's valuation are provided below:
Gross Profit
297 M
Profit Margin
0.0033
Market Capitalization
954.5 M
Enterprise Value Revenue
0.5449
Revenue
2.9 B
We have found one hundred twenty available fundamental signals for Astrana Health, which can be analyzed and compared to other ratios and to its rivals. Traders should compare all of Astrana Health prevailing fundamentals against the fundamentals between 2010 and 2026 to make sure the company is sustainable this year. The current Market Cap is estimated to decrease to about 1 B. Enterprise Value is estimated to decrease to about 1.1 B

Astrana Health Total Revenue

2.46 Billion

Check Astrana Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Astrana Health's main balance sheet or income statement drivers, such as Interest Expense of 40 M, Other Operating Expenses of 2.3 B or Operating Income of 107.9 M, as well as many indicators such as Price To Sales Ratio of 1.18, Dividend Yield of 0.0029 or PTB Ratio of 2.45. Astrana financial statements analysis is a perfect complement when working with Astrana Health Valuation or Volatility modules.
  
Build AI portfolio with Astrana Stock
Check out the analysis of Astrana Health Correlation against competitors.
For more detail on how to invest in Astrana Stock please use our How to Invest in Astrana Health guide.

Astrana Health Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets1.6 B1.6 B584.1 M
Slightly volatile
Other Current Liabilities389.4 M370.9 M103.9 M
Slightly volatile
Total Current Liabilities441.5 M420.4 M126 M
Slightly volatile
Accounts Payable18.3 M17.4 M7.8 M
Slightly volatile
Cash348.3 M331.7 M137.6 M
Slightly volatile
Cash And Short Term Investments351.2 M334.5 M152.7 M
Slightly volatile
Common Stock Total Equity30 K54 K33.3 K
Slightly volatile
Common Stock Shares Outstanding58.2 M55.5 M30.8 M
Slightly volatile
Liabilities And Stockholders Equity1.6 B1.6 B584.1 M
Slightly volatile
Non Current Liabilities Total573.7 M546.4 M178.1 M
Slightly volatile
Other Stockholder Equity514.9 M490.3 M194.6 M
Slightly volatile
Total Liabilities1 B966.8 M304.1 M
Slightly volatile
Total Current Assets771 M734.3 M263.1 M
Slightly volatile
Common Stock34.2 K55.2 K36.4 K
Slightly volatile
Short and Long Term Debt Total569.7 M542.6 M170.6 M
Slightly volatile
Short Term Debt18.4 M17.6 M7.3 M
Slightly volatile
Property Plant And Equipment Net56.6 M53.9 M29.6 M
Slightly volatile
Non Current Assets Total865.1 M823.9 M321 M
Slightly volatile
Non Currrent Assets Other76.3 M72.7 M15.8 M
Slightly volatile
Net Receivables392.2 M373.5 M100.6 M
Slightly volatile
Other Current Assets27.6 M26.3 M9.8 M
Slightly volatile
Property Plant And Equipment Gross86.4 M82.3 M35.8 M
Slightly volatile
Current Deferred Revenue1.8 M1.8 M3.5 M
Pretty Stable
Long Term Debt513.5 M489.1 M151 M
Slightly volatile
Good Will506.2 M482.1 M180 M
Slightly volatile
Long Term Debt Total245.6 M233.9 M103.4 M
Slightly volatile
Capital Surpluse434.8 M414.1 M181 M
Slightly volatile
Intangible Assets142.7 M135.9 M59.5 M
Slightly volatile
Property Plant Equipment155.7 M148.3 M50.8 M
Slightly volatile
Other Liabilities28.2 M21 M26.8 M
Very volatile
Short and Long Term Debt6.2 M10.8 M6.2 M
Slightly volatile
Long Term Investments39.7 M55.4 M30.6 M
Slightly volatile
Non Current Liabilities Other14.7 M12.6 M13.1 M
Slightly volatile
Warrants11.7 M12.3 M118 M
Slightly volatile
Capital Lease Obligations21.7 M42.7 M13.4 M
Slightly volatile
Net Invested Capital659.9 M1.3 B466.9 M
Slightly volatile
Net Working Capital229.6 M313.8 M144.4 M
Slightly volatile
Capital Stock47.1 K55.2 K39.9 K
Slightly volatile

Astrana Health Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Other Operating Expenses2.3 B2.2 B668.9 M
Slightly volatile
Selling General Administrative186.1 M177.2 M55.8 M
Slightly volatile
Total Revenue2.5 B2.3 B711.9 M
Slightly volatile
Cost Of Revenue2.1 B2 B602.8 M
Slightly volatile
Depreciation And Amortization33.7 M32.1 M13.1 M
Slightly volatile
Gross Profit327.7 M312.1 M109.1 M
Slightly volatile
Interest Income17.5 M16.7 M4.8 M
Slightly volatile
Non Recurring539.2 K567.6 K1.9 M
Slightly volatile
Reconciled Depreciation21.5 M32.1 M20.2 M
Slightly volatile
Extraordinary Items7.8 M8.7 M9.5 M
Slightly volatile

Astrana Health Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow355.2 M338.3 M121.5 M
Slightly volatile
End Period Cash Flow349.1 M332.5 M137.4 M
Slightly volatile
Depreciation33.7 M32.1 M13.1 M
Slightly volatile
Stock Based Compensation41.7 M39.7 M10.5 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio1.180.670.9907
Slightly volatile
Dividend Yield0.00290.00310.0235
Very volatile
PTB Ratio2.451.92.0986
Slightly volatile
Days Sales Outstanding35.5852.4439.6699
Slightly volatile
Book Value Per Share11.7812.45.8 M
Slightly volatile
Stock Based Compensation To Revenue0.0090.01530.0069
Slightly volatile
Capex To Depreciation0.470.260.5827
Very volatile
PB Ratio2.451.92.0986
Slightly volatile
Payables Turnover58.710554.0505
Slightly volatile
Sales General And Administrative To Revenue0.05620.06820.0713
Slightly volatile
Capex To Revenue0.00340.00360.0077
Pretty Stable
Cash Per Share6.667.016.3 M
Slightly volatile
Days Payables Outstanding3.433.6113.9718
Slightly volatile
Income Quality1.010.940.962
Slightly volatile
EV To Operating Cash Flow20.4229.0918.4312
Slightly volatile
EV To Free Cash Flow25.2434.3822.0592
Slightly volatile
Intangibles To Total Assets0.290.360.2742
Slightly volatile
Current Ratio1.941.572.1068
Slightly volatile
Receivables Turnover10.17.210.1675
Slightly volatile
Graham Number11.215.713.3823
Slightly volatile
Shareholders Equity Per Share16.3317.193.9 M
Slightly volatile
Debt To Equity0.380.60.3242
Slightly volatile
Capex Per Share0.180.19177.5 K
Slightly volatile
Average Receivables46.8 M70.4 M55 M
Slightly volatile
Revenue Per Share46.6149.0629.8 M
Slightly volatile
Interest Debt Per Share11.5712.18495 K
Slightly volatile
Debt To Assets0.170.310.1425
Slightly volatile
Enterprise Value Over EBITDA11.0810.79.4024
Slightly volatile
Operating Cycle35.5852.4439.6699
Slightly volatile
Price Book Value Ratio2.451.92.0986
Slightly volatile
Days Of Payables Outstanding3.433.6113.9718
Slightly volatile
Ebt Per Ebit1.131.041.1218
Slightly volatile
Effective Tax Rate0.30.340.2405
Slightly volatile
Company Equity Multiplier2.772.192.7977
Slightly volatile
Long Term Debt To Capitalization0.260.340.1997
Slightly volatile
Total Debt To Capitalization0.220.360.1927
Slightly volatile
Debt Equity Ratio0.380.60.3242
Slightly volatile
Quick Ratio1.941.572.1068
Slightly volatile
Cash Ratio1.120.711.2793
Very volatile
Days Of Sales Outstanding35.5852.4439.6699
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.960.970.9668
Slightly volatile
Price To Book Ratio2.451.92.0986
Slightly volatile
Fixed Asset Turnover27.5849.9129.7347
Pretty Stable
Enterprise Value Multiple11.0810.79.4024
Slightly volatile
Debt Ratio0.170.310.1425
Slightly volatile
Price Sales Ratio1.180.670.9907
Slightly volatile
Asset Turnover1.251.731.485
Slightly volatile
Gross Profit Margin0.20.150.189
Slightly volatile
Price Fair Value2.451.92.0986
Slightly volatile

Astrana Health Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap1 B1.4 B793.6 M
Slightly volatile

Astrana Fundamental Market Drivers

Forward Price Earnings23.0415
Cash And Short Term Investments290.8 M

About Astrana Health Financial Statements

Investors use fundamental indicators, such as Astrana Health's revenue or net income, to determine how well the company is positioned to perform in the future. Although Astrana Health's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Current Deferred Revenue1.8 M1.8 M
Total Revenue2.3 B2.5 B
Cost Of Revenue2 B2.1 B
Stock Based Compensation To Revenue 0.02  0.01 
Sales General And Administrative To Revenue 0.07  0.06 
Revenue Per Share 49.06  46.61 
Ebit Per Revenue 0.04  0.05 

Currently Active Assets on Macroaxis

FSLYFastly Class A
MOBMobilicom Limited American
CMGChipotle Mexican Grill
CSANCosan SA ADR
RKTRocket Companies
When determining whether Astrana Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Astrana Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Astrana Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Astrana Health Stock:
How To Invest In Astrana
Details
Is Astrana Stock a good investment?
Details
What is Astrana Health's Net Worth?
Details
Largest Health Care Providers & Services Companies
View
Largest Health Care Equipment & Services Companies
View
Check out the analysis of Astrana Health Correlation against competitors.
For more detail on how to invest in Astrana Stock please use our How to Invest in Astrana Health guide.
You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Is there potential for Health Care Providers & Services market expansion? Will Astrana introduce new products? Factors like these will boost the valuation of Astrana Health. If investors know Astrana will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about Astrana Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.98)
Earnings Share
0.19
Revenue Per Share
59.463
Quarterly Revenue Growth
0.997
Return On Assets
0.0288
The market value of Astrana Health is measured differently than its book value, which is the value of Astrana that is recorded on the company's balance sheet. Investors also form their own opinion of Astrana Health's value that differs from its market value or its book value, called intrinsic value, which is Astrana Health's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Astrana Health's market value can be influenced by many factors that don't directly affect Astrana Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
Understanding that Astrana Health's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Astrana Health represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Astrana Health's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY